| Heart disease and stroke statistics—2022 update: a report from the American Heart Association CW Tsao, AW Aday, ZI Almarzooq, A Alonso, AZ Beaton, MS Bittencourt, ... Circulation 145 (8), e153-e639, 2022 | 3901 | 2022 |
| Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ... Jama 305 (24), 2556-2564, 2011 | 1891 | 2011 |
| Heart disease and stroke statistics—2023 update: a report from the American Heart Association CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ... Circulation 147 (8), e93-e621, 2023 | 1668 | 2023 |
| Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction R Santhanakrishnan, NA Wang, MG Larson, JW Magnani, DD McManus, ... Circulation 133 (5), 484-492, 2016 | 804 | 2016 |
| Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community JE Ho, C Liu, A Lyass, P Courchesne, MJ Pencina, RS Vasan, MG Larson, ... Journal of the American College of Cardiology 60 (14), 1249-1256, 2012 | 789 | 2012 |
| Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study TJ Wang, KC Wollert, MG Larson, E Coglianese, EL McCabe, S Cheng, ... Circulation 126 (13), 1596-1604, 2012 | 563 | 2012 |
| Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction CW Tsao, A Lyass, D Enserro, MG Larson, JE Ho, JR Kizer, JS Gottdiener, ... JACC: heart failure 6 (8), 678-685, 2018 | 490 | 2018 |
| Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials DD Waters, JE Ho, DA DeMicco, A Breazna, BJ Arsenault, CC Wun, ... Journal of the American College of Cardiology 57 (14), 1535-1545, 2011 | 489 | 2011 |
| 2-Aminoadipic acid is a biomarker for diabetes risk TJ Wang, D Ngo, N Psychogios, A Dejam, MG Larson, RS Vasan, ... The Journal of clinical investigation 123 (10), 4309-4317, 2013 | 454 | 2013 |
| American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ... Heart disease and stroke statistics-2023 update: a report from the American …, 2023 | 429 | 2023 |
| Using methods from the data-mining and machine-learning literature for disease classification and prediction: a case study examining classification of heart failure subtypes PC Austin, JV Tu, JE Ho, D Levy, DS Lee Journal of clinical epidemiology 66 (4), 398-407, 2013 | 406 | 2013 |
| Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction JE Ho, A Lyass, DS Lee, RS Vasan, WB Kannel, MG Larson, D Levy Circulation: heart failure 6 (2), 279-286, 2013 | 367 | 2013 |
| Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community CSP Lam, A Lyass, E Kraigher-Krainer, JM Massaro, DS Lee, JE Ho, ... Circulation 124 (1), 24-30, 2011 | 353 | 2011 |
| The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF N Savji, WC Meijers, TM Bartz, V Bhambhani, M Cushman, M Nayor, ... JACC: Heart Failure 6 (8), 701-709, 2018 | 346 | 2018 |
| A genome-wide association study of the human metabolome in a community-based cohort EP Rhee, JE Ho, MH Chen, D Shen, S Cheng, MG Larson, A Ghorbani, ... Cell metabolism 18 (1), 130-143, 2013 | 330 | 2013 |
| Predicting heart failure with preserved and reduced ejection fraction: the international collaboration on heart failure subtypes JE Ho, D Enserro, FP Brouwers, JR Kizer, SJ Shah, BM Psaty, TM Bartz, ... Circulation: Heart Failure 9 (6), e003116, 2016 | 318 | 2016 |
| Genome‐wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease C Yao, G Chen, C Song, J Keefe, M Mendelson, T Huan, BB Sun, A Laser, ... Nature communications 9 (1), 3268, 2018 | 306 | 2018 |
| Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update N Suthahar, WC Meijers, HHW Silljé, JE Ho, FT Liu, RA de Boer Theranostics 8 (3), 593, 2018 | 272 | 2018 |
| Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study N Amabile, S Cheng, JM Renard, MG Larson, A Ghorbani, E McCabe, ... European heart journal 35 (42), 2972-2979, 2014 | 262 | 2014 |
| Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes DD Waters, JE Ho, SM Boekholdt, DA DeMicco, JJP Kastelein, M Messig, ... Journal of the American College of Cardiology 61 (2), 148-152, 2013 | 253 | 2013 |
